openPR Logo
Press release

Latest developments and breakthroughs in antibiotic resistance

02-28-2018 09:39 AM CET | Health & Medicine

Press release from: SMi Group

Superbugs & Superdrugs

Superbugs & Superdrugs

The growing global threat of antimicrobial resistance, research strategies aiming to eliminate resistance, latest scientific advancements for tackling resistance, as well as potential novel candidates and antimicrobial alternatives is the focus for SMi’s 20th annual Superbugs and Superdrugs conference. It will take place in Copthorne Tara Hotel, Kensington, London on the 19th and 20th March.

The topic of Superbugs & Superdrugs has continuously evolved and developed in the two decades the event has been running. This year, senior industry experts will be exploring the latest developments and breakthroughs in antibiotic resistance. Core issues surrounding funding and initiatives, breakthroughs in drug discovery, improving the antibiotic pipeline, resistance prevention and much more will be discussed in depth at the event.

The event will have an emphasis on the current approaches pharmaceutical companies have in developing new therapeutics & drugs, obtaining funding for new projects, and the question of why there’s a lack of incentives for researchers working in antimicrobial resistance research.

Conference highlights include how GARDP are facilitating the research and development of new antibiotics, The Pew Charitable Trusts discussing SPARK; a digital platform where researchers can share data, ideas and insights to aid new antibiotic discovery, and how Oppliotech is using a systems biology approach to develop anti-bacterials via a computational network model to help identify potentiator targets.

The event will also explore the latest novel candidates and alternatives to antibiotics, including Contrafect’s Lysin Products, as well as Professor Ian Henderson’s research using Apheresis.

Visit for more details.

+44 (0)20 7827 6000

Follow us on Social Media for latest industry and event updates
LinkedIn – search 'SMi Pharma'
Twitter – we are @SMIpharm and #smibugs

Superbugs & Superdrugs | 19th – 20th March 2018 | London, UK

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

1 Westminster Bridge Rd, South Bank, London SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Latest developments and breakthroughs in antibiotic resistance here

News-ID: 959778 • Views: 178

More Releases from SMi Group

Interview released with Head of Communications Services, NATO Headquarters ahead …
SMi reports: Steven Mehringer, Head of Communications Services, NATO Headquarters interviewed ahead of the conference in November The Social Media in the Defence and Military Sector conference 2019 will commence on 20th and 21st November and will provide the ideal platform to discuss social media strategies, platforms and tools used in the armed forces’ day-to-day activities from branding and recruitment to frontline operations, intelligence, and cyber warfare. Ahead of upcoming event taking
ELTA Systems announced to sponsor, present and exhibit Air Missile Defence Techn …
SMi reports: ELTA Systems announced as brand new sponsor for the upcoming conference in October SMi Group are delighted to announce that ELTA Systems will sponsor, present and exhibit at this year's Air Missile Defence Technology conference, taking place on the 22nd and 23rd October 2019. ELTA Systems Ltd. is a Group and wholly owned subsidiary of Israel Aerospace Industries Ltd, Israel’s leading defense supplier and a global leader in defense and
Commodore Ian Annett, Royal Navy to Present on Information Exploitation and C4I …
SMi Reports: Commodore Ian Annett to deliver keynote briefing at the 3rd annual Maritime Information Warfare conference, in London this November Building on the Royal Navy’s Exercise Information Warrior 2018/19, this year’s Maritime Information Warfare Conference, commencing on 18th – 19th November in London, has strong support from the Royal Navy and will expand on the key themes from the exercise, including Artificial Intelligence (AI), Information Exploitation and Big Data,
Military Airlift and Air-to-Air Refuelling Interviews Released with Conference C …
SMi Reports: Exclusive interviews with Avidonn Consulting, NSPA and US Air Force released for upcoming Military Airlift and Air-to-Air Refuelling Conference Ahead of the 20th annual Military Airlift and Air-to-Air Refuelling conference, taking place on 3rd – 4th December in Lisbon, SMi caught up with conference chair Laurent Donnet, Managing Director, Avidonn Consulting and key speakers Jan Der Kinderen, MMF System Manager, Aviation Support Division, NATO Support and Procurement Agency

All 5 Releases

More Releases for Superbugs

Four weeks until SMi’s 21st Annual Superbugs & Superdrugs Conference 2019
SMi Reports: Senior industry experts will gather in London to discuss the recent advances made in combating antibiotic resistance. As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. For this reason, the Superbugs & Superdrugs conference, taking
Registration Officially Opens for the 21st Annual Superbugs & Superdrugs Confere …
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicine are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019 ( This
Kidney Infection Market | Superbugs | CAGR 5.2% | USA | PDF | PPT | Case Reports …
Kidney infection is a result of infection in the bladder that spreads to the kidney. Most common bacteria causing kidney infection is E. coli. Kidney infections are very common, especially, an aging population. The blood test is performed to make sure that the kidneys are functioning normally. The urine test, called a urinalysis, detects any abnormal cells or proteins that relate to a kidney problem. If the blood and urine
W. J. Wiess and A.S. Lynch invitation to SMi’s Superbugs & Superdrugs USA Conf …
SMi Group reports: William J. Weiss - University of North Texas Health Science Center and Anthony Simon Lynch - Janssen supporting SMi's Superbugs & Superdrugs USA Conference, which is due to take place this November in New Jersey William and Anthony are chairing SMi's Superbugs & Superdrugs USA Conference and encourage all involved in AMR to join experts from multiple disciplines, in the field of infectious disease representing research, regulatory, funding,
Superbugs & Superdrugs USA Conference returns to New Jersey this November
SMi Group reports: agenda released for 3rd annual Superbugs & Superdrugs USA conference Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group is pleased to announce the release of the official agenda for the 3rd annual Superbugs & Superdrugs USA Conference, which is due to take place in Iselin, New Jersey on November 12 - 13, 2018. Antimicrobial resistance, leading to the
Superbugs: Exclusive Interviews Released with ABAC Therapeutics, Alchemy Biomedi …
SMI REPORTS: Expert insight into tackling the scientific, regulatory and economic challenges to combat antimicrobial resistance. It is imperative for medical experts and drug discovery specialists to stay on top of the latest clinical advancements, developments and industry initiatives related to antimicrobial resistance. For this reason, SMi Group have gathered industry experts and government bodies to share their insights at the 20th annual conference on Superbugs and Superdrugs taking place on